BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Luis M, Tavares A, Carvalho LS, Lara-Santos L, Araújo A, Mello RA. Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies. World J Gastroenterol 2013; 19(38): 6383-6397 [PMID: 24151357 DOI: 10.3748/wjg.v19.i38.6383]
URL: https://www.wjgnet.com/2307-8960/full/v19/i38/6383.htm
Number Citing Articles
1
Yujing Zhou, Chunhua Liu, Yongcan Huang. Wireless Power Transfer for Implanted Medical Application: A ReviewEnergies 2020; 13(11): 2837 doi: 10.3390/en13112837
2
Onur CEYLAN, Sevilay ÖZMEN. Prognostic Significance of HER-2 Expression in Gastric CancerBlack Sea Journal of Health Science 2021; 4(2): 52 doi: 10.19127/bshealthscience.836510
3
Ramon Andrade De Mello, Luis Castelo-Branco, Pedro Castelo-Branco, Daniel Humberto Pozza, Louis Vermeulen, Sofia Palacio, Matthew Salzberg, A. Craig Lockhart. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?American Society of Clinical Oncology Educational Book 2018; (38): 249 doi: 10.1200/EDBK_198805
4
Julie Giraud, Silvia Molina‐Castro, Lornella Seeneevassen, Elodie Sifré, Julien Izotte, Camille Tiffon, Cathy Staedel, Hélène Boeuf, Solène Fernandez, Philippe Barthelemy, Francis Megraud, Philippe Lehours, Pierre Dubus, Christine Varon. Verteporfin targeting YAP1/TAZ‐TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cellsInternational Journal of Cancer 2020; 146(8): 2255 doi: 10.1002/ijc.32667
5
Hongbo Zhou, Ailian Dong, Hui Xia, Guangmei He, Jianghe Cui. Associations between CA19‑9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancerOncology Letters 2018;  doi: 10.3892/ol.2018.8731
6
Yasuhiro Oono, Takeshi Kuwata, Kenji Takashima, Kensuke Shinmura, Keisuke Hori, Yusuke Yoda, Hiroaki Ikematsu, Kohei Shitara, Takahiro Kinoshita, Tomonori Yano. Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samplesGastric Cancer 2019; 22(2): 335 doi: 10.1007/s10120-018-0853-7
7
SU-QING ZHANG, KE-KANG SUN, XIAO-YANG WU, NING ZHONG, HUA ZHAO, DE-CHUN LI. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancerMolecular Medicine Reports 2015; 12(1): 1177 doi: 10.3892/mmr.2015.3470
8
Pedro Nazareth Aguiar, Thiago Pimentel Muniz, Raelson Rodrigues Miranda, Hakaru Tadokoro, Nora Manoukian Forones, Ines-de-Paula Monteiro, Pedro Castelo-Branco, Yelena Y Janjigian, Ramon Andrade de Mello. Current advances in targeted therapies for metastatic gastric cancer: improving patient careFuture Oncology 2016; 12(6): 839 doi: 10.2217/fon.15.348
9
Zijun Guo, Lin Guo. Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progressionInternational Journal of Clinical Oncology 2024; 29(4): 442 doi: 10.1007/s10147-024-02478-3
10
Jian He, Hua Shi, Zhuping Zhou, Jun Chen, Wenxian Guan, Hao Wang, Haiping Yu, Song Liu, Zhengyang Zhou, Xiaofeng Yang, Tian Liu. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot studyBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1726-7
11
Phu Hung Nguyen, Julie Giraud, Lucie Chambonnier, Pierre Dubus, Linda Wittkop, Geneviève Belleannée, Denis Collet, Isabelle Soubeyran, Serge Evrard, Benoit Rousseau, Nathalie Senant-Dugot, Francis Mégraud, Frédéric Mazurier, Christine Varon. Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric CarcinomaClinical Cancer Research 2017; 23(6): 1586 doi: 10.1158/1078-0432.CCR-15-2157
12
Gretel Terrero, A. Craig Lockhart. Role of Immunotherapy in Advanced Gastroesophageal CancerCurrent Oncology Reports 2020; 22(11) doi: 10.1007/s11912-020-00975-y
13
Xin-Yuan Liu, Tian-Qi Zhang, Qi Zhang, Jing Guo, Peng Zhang, Tao Mao, Zi-Bin Tian, Cui-Ping Zhang, Xiao-Yu Li. Differential Long Non-Coding RNA Expression Analysis in Chronic Non-Atrophic Gastritis, Gastric Mucosal Intraepithelial Neoplasia, and Gastric Cancer TissuesFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.833857
14
Sadeque Reza Khan, Sumanth Kumar Pavuluri, Gerard Cummins, Marc P. Y. Desmulliez. Wireless Power Transfer Techniques for Implantable Medical Devices: A ReviewSensors 2020; 20(12): 3487 doi: 10.3390/s20123487
15
Byungho Lim, Jong-Hwan Kim, Mirang Kim, Seon-Young Kim. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancerWorld Journal of Gastroenterology 2016; 22(3): 1190-1201 doi: 10.3748/wjg.v22.i3.1190
16
Md Basar, Mohd Ahmad, Jongman Cho, Fatimah Ibrahim. Application of Wireless Power Transmission Systems in Wireless Capsule Endoscopy: An OverviewSensors 2014; 14(6): 10929 doi: 10.3390/s140610929
17
Weipeng Lu, Mei Li, Hai Wang, Lina Liu, Shen Lu. An epidermal growth factor receptor exon 19 mutation in a mucin-producing gastric cancer sample from a Chinese patientJapanese Journal of Clinical Oncology 2016; 46(6): 502 doi: 10.1093/jjco/hyw033
18
Tengyang Ni, Haibo Wang, Dongmei Zhan, Li Tao, Mengying Lv, Weimin Wang, Zewen Chu, Zhen Zhou, Masataka Sunagawa, Yanqing Liu. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant featuresLife Sciences 2021; 269: 119021 doi: 10.1016/j.lfs.2021.119021
19
Ramon Andrade De Mello. Gastric Cancer in Southern Europe: High-Risk DiseaseAmerican Society of Clinical Oncology Educational Book 2017; (37): 261 doi: 10.1200/EDBK_175227
20
B. Sushma. Sustainable Communication Networks and ApplicationLecture Notes on Data Engineering and Communications Technologies 2021; 55: 275 doi: 10.1007/978-981-15-8677-4_23
21
Keishiro Aoyagi, Kikuo Kouhuji, Junya Kizaki, Taro Isobe, Kousuke Hashimoto, Kazuo Shirouzu. Molecular targeting to treat gastric cancerWorld Journal of Gastroenterology 2014; 20(38): 13741-13755 doi: 10.3748/wjg.v20.i38.13741
22
S. T. Kim, I.-G. Do, J. Lee, I. Sohn, K.-M. Kim, W. K. Kang. The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancerClinical and Translational Oncology 2015; 17(6): 462 doi: 10.1007/s12094-014-1258-7
23
Ramon Andrade de Mello, Jailson de Oliveira, Georgios Antoniou. Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer?Future Oncology 2017; 13(4): 295 doi: 10.2217/fon-2016-0318